Wikisage, the free encyclopedia of the second generation, is digital heritage
Perampanel: Difference between revisions
Jump to navigation
Jump to search
m (chemical) |
m (wLink) |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<gallery>File:Perampanel_molecule_ball.png</gallery> | <gallery>File:Perampanel_molecule_ball.png</gallery> | ||
(Fycompa) is an AED | |||
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/26370209 Perampanel: A Review in Drug-Resistant Epilepsy]</ref> | |||
5′-(2-Cyanphenyl)-1′-phenyl-2,3′-bipyridinyl-6′(1′H)-on | 5′-(2-Cyanphenyl)-1′-phenyl-2,3′-bipyridinyl-6′(1′H)-on | ||
<ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf</ref> | <ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf</ref> | ||
Perampanel was efficacious and well tolerated, despite the observation that the patient population exhibited characteristics of highly refractory [[epilepsy]] | |||
<ref>http://n.neurology.org/content/suppl/2016/04/10/WNL.0000000000001930.DC3/french_950.pdf</ref> | |||
==ATC== | ==ATC== | ||
https://www.whocc.no/atc_ddd_index/?code=N03AX22 | https://www.whocc.no/atc_ddd_index/?code=N03AX22 | ||
[http://onlinelibrary.wiley.com/doi/10.1111/epi.12212/full Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies] | |||
{{wikidata|Q868658}} | |||
<references/> | <references/> | ||
[[Category:Anticonvulsant]] | |||
Revision as of 19:24, 10 January 2018
(Fycompa) is an AED [1] 5′-(2-Cyanphenyl)-1′-phenyl-2,3′-bipyridinyl-6′(1′H)-on
[2] Perampanel was efficacious and well tolerated, despite the observation that the patient population exhibited characteristics of highly refractory epilepsy
